Ventana to collaborate with BI on companion diagnostics, 11/13

Create PDF

Ventana Medical Systems and Boehringer Ingelheim have entered into an agreement to collaborate on the development of companion diagnostic tests for Boehringer Ingelheim oncology programs.

As part of the agreement, Ventana will use its immunohistochemistry technology platform, experience, and expertise in companion diagnostics development and premarket approval submissions to support BI’s personalized medicine strategies for cancer drug development.

Ventana Medical Systems, 520-877-7288